Newsroom

Celdara Medical Awarded SBA Regional Innovation Cluster Award to Expand DRIVEN Program Funding to Accelerate Biotech Innovation in New England and Beyond

October 4, 2024 Stephanie Mack

Lebanon, NH – Celdara Medical, a leader in preclinical biotech development, is excited to announce it has been awarded funding from the U.S. Small Business Administration’s (SBA) Regional Innovation Cluster (RIC) program. This prestigious award will further expand Celdara’s DRIVEN program, designed to support entrepreneurs and early-stage companies in the biotech and life sciences sectors. Since its inception in 2018, DRIVEN has propelled numerous companies […]

Celdara Medical Appoints Dr. Wayne Frederick as Board Advisor

February 8, 2024 Stephanie Mack

LEBANON, N.H.—Celdara Medical today announced today announced the appointment of Dr. Wayne Frederick, MD, MBA as advisor to its board of directors. Dr. Frederick is President Emeritus of Howard University and the Charles R. Drew Professor of Surgery at the Howard University College of Medicine. He is an active board […]

Celdara Medical Appoints Lynne Parshall to its Board of Directors

February 8, 2024 Stephanie Mack

LEBANON, N.H.—Celdara Medical today announced the appointment of Lynne Parshall, JD to the company’s board of directors. “Lynne is an inspiring leader who knows exactly what it takes to transform world-changing concepts into valuable medicines. Her tenure as founding COO and Director at Ionis clearly demonstrates her thought leadership, delivering […]

Celdara Medical and C-Path’s Translational Therapeutics Accelerator Announce Pipeline-focused Partnership

November 29, 2023 Stephanie Mack

LEBANON, N.H. and TUCSON, Ariz.– Celdara Medical and Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look […]

Celdara Medical Awarded SBIR Fast-Track Funding for Development of Cell Therapy for Amyotrophic Lateral Sclerosis

October 12, 2023 Celdara Medical

Lebanon, NH: The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded Celdara Medical a Fast-Track Small Business Innovation Research (SBIR) grant to fund the development of engineered regulatory T cells (Tregs) therapy for Amyotrophic Lateral Sclerosis (ALS). ALS is a debilitating […]

Call for Applications: Celdara Medical High Potential Entrepreneurs’ Fellowship 2023-24

August 10, 2023 Celdara Medical

Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development. Program Description 1-year experiential learning to gain real-world experience in biotechnology Develop executive skills including […]

Celdara Medical Awarded Phase II SBIR Funding to Develop Therapeutics for Pandemic-Potential Influenza Strains

August 8, 2023 Celdara Medical

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]

Celdara Medical and University of Vermont Funded to Develop Therapeutic Antibodies for Hantavirus Cardiopulmonary Syndrome

June 14, 2023 Celdara Medical

Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]

Scientist

April 26, 2023 Celdara Medical

Position Description Celdara Medical, LLC (CM) is building a portfolio of early-stage medical companies in collaboration with leading academicians. Each of these is at a different stage of development with a different development path. Celdara aims to bring these products to market with urgency. Our Mission is to give hope […]

DRIVEN Partner Companies Surpass $100M in Follow-on-Funding

March 6, 2023 Celdara Medical

Lebanon, NH: Celdara Medical, LLC announced today that participants in the inaugural DRIVEN Accelerator Hub Partner Program have collectively surpassed $100M in follow-on funding. Led by Celdara Medical and Simbex, and with seed funding from National Institute of General Medicine Sciences (NIGMS), the DRIVEN Accelerator Hub was established in 2018 […]